Hawaii Drug Testing Laws & Workplace Regulations

Hawaii Drug Testing Laws for Employers: A DOT and Non DOT Compliance Guide

Hawaii regulates employer drug testing by statute, and it does so in a way that catches mainland employers off guard. The state imposes specific procedural requirements on how testing must be conducted, including a laboratory licensing requirement that has no equivalent in most states. Hawaii also has an explicit constitutional right to privacy that shapes how testing programs are evaluated.

At US Drug Test Centers, we work with Hawaii employers across the islands to build programs that meet both the federal DOT framework and Hawaii's statutory testing standards.

The Two Tracks

Federal DOT testing under 49 CFR Part 40 applies to employees performing safety sensitive functions in regulated transportation industries. Hawaii law does not alter it, and Hawaii's medical cannabis provisions do not reach it.

Non DOT testing operates under Hawaii Revised Statutes chapter 329B and your written policy. The procedural requirements there are meaningfully different from what you would follow on the mainland.

Keep the two programs separate, with separate random pools and separate documentation.

DOT Drug and Alcohol Testing in Hawaii

Hawaii's geography makes DOT regulated work unusually central to daily life. Interisland and mainland aviation, harbor and marine operations, commercial trucking, and public transit all carry federal testing obligations.

• Covered Employee Groups The Federal Aviation Administration covers pilots, flight crew, mechanics, dispatchers, and other aviation safety sensitive employees, a large and critical population in Hawaii. The U.S. Coast Guard covers crewmembers on commercial vessels, including interisland cargo and passenger operations. The Federal Motor Carrier Safety Administration covers CDL drivers operating commercial motor vehicles. The Federal Transit Administration covers employees at federally funded transit agencies, including TheBus and rail operations on Oahu. The Pipeline and Hazardous Materials Safety Administration covers pipeline operations and maintenance personnel.
• The Federal Panel and Thresholds DOT testing uses a five panel urine screen analyzed by a laboratory certified by the Department of Health and Human Services: marijuana, cocaine, opiates including hydrocodone, hydromorphone, oxycodone, and oxymorphone, amphetamines including methamphetamine and MDMA, and phencyclidine. Alcohol testing uses evidential breath testing devices, with a violation at 0.04 and required removal from duty at 0.02. A Medical Review Officer reviews every non negative laboratory result and evaluates any legitimate medical explanation before verifying it.
• Required Testing Events Pre employment before performing a safety sensitive function. Random at the annual rates set by each operating administration, spread reasonably throughout the year. Reasonable suspicion based on specific, articulable observations by a trained supervisor. Post accident under agency specific criteria. Return to duty and follow up testing directed by a Substance Abuse Professional.
• Clearinghouse Requirements Hawaii motor carriers must complete full pre-employment queries in the FMCSA Drug and Alcohol Clearinghouse, run limited queries annually on current CDL drivers, and report violations and refusals.

Hawaii Medical Cannabis Provides No DOT Protection A Hawaii medical cannabis registration card offers no defense in a DOT test. Marijuana remains federally prohibited for safety-sensitive transportation workers, and a Medical Review Officer may not verify a marijuana positive as negative based on any state registration.

Because DOT collections must occur at qualified sites and specimens must reach certified laboratories, Hawaii employers should also plan for logistics. Interisland specimen transport and turnaround times require a collection network built for the state rather than adapted to it.

Non DOT Drug Testing Laws in Hawaii

• Hawaii Revised Statutes Chapter 329B Hawaii's substance abuse testing statute imposes real procedural requirements on employers. This is the framework that governs non DOT testing in the state. The central requirement is laboratory licensing. Under chapter 329B, substance abuse testing must generally be performed by a laboratory that is licensed or certified under Hawaii law, or that meets the standards the statute recognizes. Employers cannot simply route Hawaii specimens to any convenient mainland facility without confirming that the laboratory satisfies the statutory standard. This is the single most common compliance gap we find with mainland employers who have Hawaii operations. The statute also requires that employers provide the individual being tested with a written list of the substances the employer intends to test for, and information about substances, including over the counter and prescription medications, that may affect the accuracy of the test. The individual must be given an opportunity to provide information about medications or other explanations relevant to a positive result. Confirmation testing is required. An initial positive screening result must be confirmed by a reliable analytical method before it may be reported or acted upon. Results must be kept confidential and disclosed only as the statute permits. Hawaii law also addresses on site screening. Under the statute, on site screening tests may be used in defined circumstances, but a positive on site result must be confirmed through a licensed laboratory before the employer takes adverse action. Employers using instant testing devices in Hawaii should confirm their process satisfies these requirements.
• The Constitutional Privacy Right Article I, section 6 of the Hawaii Constitution contains an express right to privacy. Hawaii courts have treated this as a substantive protection, and it is a meaningful consideration in evaluating suspicionless testing, particularly for public sector employers and for employees in non safety sensitive roles. Private employers in Hawaii should be prepared to articulate a business justification for the scope of their testing program. Pre employment testing of applicants and reasonable suspicion testing of employees rest on firmer ground than broad random testing of incumbent employees in positions with no safety component.
• Cannabis in Hawaii Hawaii established a medical cannabis program in 2000 and has since expanded it to include licensed dispensaries. The medical cannabis statute has generally been understood not to require employers to accommodate cannabis use in the workplace or to permit employees to work while impaired. Hawaii has decriminalized possession of small amounts of cannabis but has not legalized adult use, despite repeated legislative efforts. Non medical cannabis use remains unlawful under state law. Hawaii's cannabis and employment landscape has been an active area of legislative attention, and provisions affecting employees have been proposed and amended in recent sessions. Employers should verify the current state of the law before relying on any specific provision, and should have a Hawaii attorney confirm how the medical cannabis statute interacts with their policy.
• Workers Compensation and Unemployment Hawaii workers compensation law allows for the denial of benefits where the injury was caused by the employee's intoxication, and a properly conducted post accident test performed under a compliant program is the evidentiary foundation. On the unemployment side, a discharge for willful misconduct connected with work, including violation of a known drug policy, can affect benefit eligibility. In both settings, chain of custody and statutory compliance determine whether the result is usable.

Building a Defensible Hawaii Program

Confirm that your laboratory meets Hawaii's licensing or certification requirement before you send a single specimen. Provide the written list of substances tested for and the medication information the statute requires. Give employees a genuine opportunity to explain a positive result. Require confirmation testing before any adverse action, including after an on site screen. Keep results confidential. Limit random testing of non DOT employees to positions with a documented safety justification. Train supervisors on reasonable suspicion documentation focused on observable behavior. Maintain separate DOT and non DOT pools. Plan your collection and transport logistics island by island. Have Hawaii counsel review the policy before implementation, and review it annually.

How US Drug Test Centers Supports Hawaii Employers

We maintain collection sites on Oahu, Maui, Hawaii, and Kauai, with laboratory relationships and specimen handling designed around Hawaii's licensing requirements and interisland logistics. We provide Medical Review Officer services, DOT random pool management, Clearinghouse query and reporting support, supervisor reasonable suspicion training, and policy development built around Hawaii Revised Statutes chapter 329B.

Contact US Drug Test Centers to build a Hawaii program that meets the state's statutory standards.